How much funding has Canomiks raised?

Canomiks has raised $1.1M in total funding, most recently a seed round.

Who are Canomiks's investors?

Canomiks's investors include SOSV, IndieBio, US National Science Foundation.

Where is Canomiks headquartered?

Canomiks is headquartered in Cambridge, Massachusetts, United States.

What industry is Canomiks in?

Canomiks operates in Artificial Intelligence, Healthcare, Sustainability, Biotech.

Canomiks

Making Food as Medicine a Reality

Cambridge, United States · Founded 2020 · $1.1M raised

Artificial Intelligence

Healthcare

Sustainability

Biotech

Headquarters: Cambridge, Massachusetts
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: canomiks.com
Total Funding: $1.1M
Last Round: $135K SeedJun 2024
Rounds: 2

About

Canomiks is the first technology company to use a genomics and AI-based platform to validate, test, and certify the biological efficacy and safety of botanical ingredients and formulations in the functional food, beverage, dietary supplement, and skincare industries. Founded by three Harvard professors with over 50 years of combined expertise in bioinformatics, genomics, medicine, and pharmacology, Canomiks works with ingredient suppliers, finished product manufacturers, and retailers to bring science-backed, pre-clinical validation to the natural products industry. The company's mission — 'Make Food as Medicine a Reality' — is partly funded by the National Science Foundation (NSF) via SBIR grants.

Summary

Canomiks is an Artificial Intelligence company based in Cambridge, United States, founded in 2020. It has raised $1.1M in total across 2 rounds, most recently a $135K Seed round in Jun 2024. Investors include SOSV, IndieBio and US National Science Foundation.